跳至主要内容
临床试验/NCT01825070
NCT01825070已完成不适用

The Influence of Tart Montmorency Cherries on Indices of Uric Acid Metabolism

Northumbria University2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Change in uric acid

研究概览

简要总结

Cherries have been show to possess the ability to reduce uric acid concentrations and inflammation. Tart Montmorency cherries possess a higher concentration of the plant compounds than other cherries and hence makes the expectation possible that Montmorency cherries will lower uric acid and inflammation.

详细描述

Plasma and urinary uric acid concentration, plasma phytochemical content and inflammatory biomarkers will be measured in order to elucidate the effects of an acute dose of tart cherry juice on indices related to the condition of gout.

Participants will be required to attend the laboratory at a range of time points over two periods of 96 hours, separated by a 7 day washout period, to provide blood samples. In order to provide a baseline sample, participants will attend the laboratory in the morning following an overnight fast and voiding of any urine. Following this participants will be given 30mls (30 mls provides 323 mg/380 µmol of anthocyanins) of tart cherry juice or placebo, diluted with 60 mls of water to consume within 10 minutes. Participants will be required to consume identical dosages of the supplement immediately prior to evening meals and breakfasts (or same time each morning following blood sampling if non-breakfast eater) over the next 96 hours. Further blood and urine samples will be collected at 1, 2, 3, 5, 8, 24, 26, 48, 50, 72, 74 and 96 hours and will require participants to return to the laboratory at each of these time points. Following the first period of supplementation participants will complete a 7 day washout period in which they will not be required to attend the laboratory. Following the washout period they will repeat the supplementation period consuming the supplement they did not receive during the first period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • apparently healthy males/females between the ages of 18-40 years

排除标准

  • underlying clinical pathology

结局指标

主要结局

Change in uric acid

时间窗: 0, 1, 2, 3, 5, 8, 24, 26, 48 hours

measurement of changes in uric acid over a 48h period

次要结局

  • Change in C-reactive protein(0,1,2,3,5,8,24,26,48 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Glyn Howatson

Dr

Northumbria University

研究点 (2)

Loading locations...

相似试验